Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx [Phase 2]
A Phase 2 trial evaluating SBRT combined with PD-1/PD-L1 inhibiting therapy in advanced solid tumors after disease control on PD-1/PD-L1 the…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Tepotinib in Solid Tumors Harboring MET Alterations [Phase 2]
Phase 2 trial update for tepotinib in solid tumors with MET alterations, including MET exon 14 skipping and MET amplification.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients [Phase 1]
Phase 1 pharmacokinetic and safety study of niraparib in patients with normal or moderate hepatic impairment has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors [Phase 1, Phase 2]
A study evaluating SHR2150 (TLR7 agonist) in combination with chemotherapy plus PD-1 or CD47 antibody for unresectable/metastatic solid tumo…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors [Phase 2]
Phase 2 trial evaluating radiotherapy with irinotecan and apatinib followed by PD-1 antibody and apatinib for advanced solid tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. [Phase 1]
A Phase 1 study assessing safety, performance, and bioavailability of entrectinib in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update of enzastaurin in Chinese patients with advanced/metastatic solid tumors or lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating topotecan plus sargramostim in adults with advanced cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma [Phase 1]
Phase 1 study of MLN2480 in relapsed/refractory solid tumors with dose expansion in metastatic melanoma has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001) [Phase 1]
Phase 1 trial evaluating MK-4166 alone and with pembrolizumab (MK-3475) in advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin [Phase 1]
Phase 1 trial update evaluating the interaction between LY317615 and warfarin to assess metabolic pathway effects; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276 [Phase 1, Phase 2]
Clinical trial update for 4SCAR-276 targeting CD276 (B7-H3) in solid tumors across Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Update on a phase 1/2 trial evaluating mogamulizumab in combination with nivolumab for locally advanced or metastatic solid tumors; results …
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) [Phase 1, Phase 2]
A combination trial of epacadostat with pembrolizumab and chemotherapy in advanced or metastatic solid tumors has completed Phase 1/2 with r…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Safety Study of PLX108-01 in Patients With Solid Tumors [Phase 1]
Phase 1 safety study of PLX108-01 in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001) [Phase 1]
Phase 1 trial of MK-8353 in advanced solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy [Phase 2]
Phase 2 trial update exploring genomics-based targeted therapy for children with relapsed or refractory malignancies.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion trial of NC-6300 in advanced solid tumors and soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial of atezolizumab in pediatric and young adult participants with solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: A Study of HMPL-453 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for HMPL-453 in adults with advanced solid malignancies (solid tumors).
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial assessing talazoparib's impact on cardiac repolarization in patients with advanced solid tumors has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor [Phase 2]
Phase 2 basket study investigating Pyrotinib Maleate in HER2-positive solid tumors; current status and conditions listed but no results repo…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003) [Phase 1]
Phase I study of MK-2206 in combination with standard chemotherapy in locally advanced or metastatic solid tumors has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor [Phase 1, Phase 2]
Phase I/II clinical trial update for BAT1306 and BAT8001 in patients with solid tumors; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001) [Phase 1]
Phase 1 trial of MK-1248 with and without pembrolizumab in participants with advanced solid tumors was terminated.